Orlando Health Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Sensydia develops non-invasive wireless cardiac monitoring technology using machine learning to diagnose and manage heart disease.
AI & Machine LearningHardwareHealthtechMedical DevicesLos Angeles, US
Anthony Arnold(CEO)inDr. Aman Mahajan(CMO)Rusty Page(President & COO)in
BoardG. Bradford Jones(Director)William Kaiser(Executive Officer)inVictoria K. Grace(Director)in
Co-investorsColle Capital PartnersFrontier Venture Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.